opregen® phase i/iia clinical study results
Published 4 years ago • 769 plays • Length 11:56Download video MP4
Download video MP3
Similar videos
-
58:45
introducing opregen® from lineage cell therapeutics
-
5:31
sonia cohen's opregen story
-
9:34
lineage cell therapeutics - cell therapy programs
-
3:27
kol panel on dry amd discusses opregen
-
4:52
cheri's story | opregen for dry amd | lineage cell therapeutics
-
15:20
lineage cell therapeutics
-
2:27
lineage cell therapeutics | opregen for dry amd | ivanhoe broadcast news
-
25:56
opregen presentation - h.c. wainwright ophthalmology conference, aug 17, 2021
-
3:03
lineage cell therapeutics' opc1 program - patient spotlight
-
17:59
lineage cell therapeutics
-
19:09
new treatments with cell-based therapy - lineage cell therapeutics (nyse american: lctx)
-
4:50
lineage cell therapeutics' opc1 program - lucas lindner's story
-
2:09
spinal cord injury and lineage's opc1 cell therapy
-
13:16
adaptimmune
-
32:40
brian culley, ceo of lineage cell therapeutics $lctx joins us to discuss top line results for amd
-
19:51
proprietary cell therapy platform - lineage cell therapeutics (nyse american: lctx) presents at gcff
-
35:16
ois podcast ep #368: credibility, cash, and capability: the benefits of strategic partnership
-
1:02:41
advances in the clinical development of oligodendrocyte progenitor cells to treat spinal cord injury